Pyrazolobenzodiazepines: part I. Synthesis and SAR of a potent class of kinase inhibitors.
Liu, J.J., Daniewski, I., Ding, Q., Higgins, B., Ju, G., Kolinsky, K., Konzelmann, F., Lukacs, C., Pizzolato, G., Rossman, P., Swain, A., Thakkar, K., Wei, C.C., Miklowski, D., Yang, H., Yin, X., Wovkulich, P.M.(2010) Bioorg Med Chem Lett 20: 5984-5987
- PubMed: 20832307 
- DOI: 10.1016/j.bmcl.2010.08.079
- Primary Citation of Related Structures:  
3LE6 - PubMed Abstract: 
A novel series of pyrazolobenzodiazepines 3 has been identified as potent inhibitors of cyclin-dependent kinase 2 (CDK2). Their synthesis and structure-activity relationships (SAR) are described. Representative compounds from this class reversibly inhibit CDK2 activity in vitro, and block cell cycle progression in human tumor cell lines ...